A patient with systemic lupus erythematosus is prescribed hydroxychloroquine. Which of the following statements by the patient indicates a good understanding regarding the medication?

Choice A rationale Hydroxychloroquine is an antimalarial and immunomodulator that can affect the immune response. While it is not as profoundly immunosuppressive as high-dose corticosteroids or biologics, receiving live-attenuated vaccines like MMR (measles, mumps, rubella) while on therapy requires cautious clinical judgment. The patient's statement that they can "safely" receive them without qualification suggests a potential misunderstanding of how the drug affects the immune system's ability to respond to live pathogens, which could lead to vaccine-induced illness. Choice B rationale Hydroxychloroquine can cause retinal toxicity, leading to irreversible vision loss if not detected early. This occurs due to the drug binding to melanin in the retinal pigment epithelium. A baseline ophthalmic exam is required within the first year of starting therapy to document any pre-existing conditions. Follow-up exams, typically annually after five years of use or sooner if high-risk factors exist, are essential to monitor for early signs of retinopathy, ensuring the medication is discontinued before permanent damage. Choice C rationale Alcohol consumption is generally discouraged while taking hydroxychloroquine because both substances are metabolized by the liver. Chronic alcohol use can increase the risk of hepatotoxicity and may exacerbate the gastrointestinal side effects of the medication, such as nausea or abdominal cramps. Furthermore, systemic lupus erythematosus itself often involves multi-organ systems, including the liver. Suggesting that unlimited alcohol intake is safe demonstrates a lack of understanding regarding the metabolic demands placed on the body during pharmacological therapy. Choice D rationale Visual changes, such as blurred vision, halos around lights, or difficulty focusing, are never considered harmless side effects of hydroxychloroquine. These symptoms may indicate early retinal damage or corneal deposits. If a patient experiences any alteration in their visual field, they must report it immediately to their healthcare provider and stop the medication until an ophthalmologist can perform a thorough evaluation. Dismissing these symptoms as expected side effects could lead to permanent blindness for the client.